Newswire

MedPharm Adds First-to-File Generic Topical Drug to Portfolio

Interior of a pharmaceutical manufacturing facility

MedPharm has expanded its commercial manufacturing business with a new agreement to manufacture and supply a first-to-file generic topical drug product. This addition marks the company’s sixth commercial manufacturing deal in the past 22 months, reflecting ongoing momentum in its business and increasing demand for specialized topical drug development and manufacturing services.

The latest agreement also expands MedPharm’s commercial capabilities into first-to-file generic topical products. Manufacturing will occur at the company’s 110,000-square-foot facility in Durham, North Carolina, which features dedicated production infrastructure, analytical testing capabilities, and an experienced technical team to support commercial-scale manufacturing and product supply.

CEO Bill Humphries stated, “This agreement is another important step in our continued growth.” The addition of a first-to-file generic topical product showcases the range of programs the team can support and the strength of their specialized expertise.

Source: drug-dev.com · Image: Gov. Wolf Celebrates Job Creation with Ribbon Cutting for New Pharmaceutical Manufacturer in York County (51582005376) by Governor Tom Wolf from Harrisburg, PA, CC BY 2.0, via Wikimedia Commons

For investors and analysts: See in seconds what each company actually manufactures, together with its certificates and compliance status. This isn’t marketing language — it’s factual data on APIs, FDFs, dossiers, and direct producer contacts.
Open the full market picture for your next decision →